Phendimetrazine

This classification denotes a cns stimulant and anorexiant with the molecular formula C12H17NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) AB2794W8KV, chemically known as 3,4-dimethyl-2-phenylmorpholine but more generally known as phendimetrazine, which bears US NIH Compound Identifier 12460. European Medicines Agency schedules Phendimetrazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09756MIG. The term PHENDIMETRAZINE is an International Non-Proprietary Name. PHENDIMETRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule phendimetrazine under HS 29349100 and SITC 51579. As of Q4 2014, PHENDIMETRAZINE remains US FDA's Preferred Term for this commodity. Phendimetrazine bears US NLM identifiers UMLS ID C0070549 and NCI Concept Code C61887. SMILES: CC1C(OCCN1C)C2=CC=CC=C2.